Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

Autor: Stradella, Agostina1 (AUTHOR), Johnson, Melissa2 (AUTHOR), Goel, Sanjay3 (AUTHOR), Park, Haeseong4,5 (AUTHOR), Lakhani, Nehal6 (AUTHOR), Arkenau, Hendrik‐Tobias7 (AUTHOR), Galsky, Matthew D.8 (AUTHOR), Calvo, Emiliano9 (AUTHOR), Baz, Vicente10 (AUTHOR), Moreno, Victor11 (AUTHOR), Saavedra, Omar12 (AUTHOR), Luen, Stephen J.13,14 (AUTHOR), Mu, Song15 (AUTHOR), Wan, Qiting16 (AUTHOR), Chang, Victoria17 (AUTHOR), Zhang, Wa16 (AUTHOR), Barve, Minal18 (AUTHOR) mbarve@marycrowley.org
Zdroj: Cancer Medicine. Jul2024, Vol. 13 Issue 13, p1-19. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje